Antipsychotic drug use in Canadian long-term care facilities: Prevalence, and patterns following resident relocation

International Psychogeriatrics

Volumn 17, Issue 2, 2005, Pages 179-193

  Hagen, Brad ^a   Esther, Chris Armstrong ^a   Ikuta, Roland ^b   Williams, Robert J ^a   Le Navenec, Carole Lynne ^c   Aho, Morgan ^d  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

^b Senior's Health   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d NONE

Author keywords

Aged; Antipsychotic agents; Dementia; Drug utilization review; Long term care; Nursing homes; Parkinson's disease; Relocation; Skilled nursing facilities

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

AGED; ARTICLE; CANADA; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DRUG DOSE REDUCTION; FEMALE; HEALTH CARE FACILITY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PARKINSON DISEASE; PRESCRIPTION; SCHIZOPHRENIA;

ADAPTATION, PSYCHOLOGICAL; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CANADA; DEMENTIA; HUMANS; LIFE CHANGE EVENTS; LONG-TERM CARE; PARKINSON DISEASE; PATIENT TRANSFER; PREVALENCE; RESIDENTIAL FACILITIES; STRESS, PSYCHOLOGICAL;

EID: 23044461763     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610205001730     Document Type: Article

References (37)

1. Anthony, K., Procter, A. W., Silverman, A. M. and Murphy, E. (1987). Mood and behavior problems following the relocation of elderly patients with mental illness. Age and Ageing, 16, 355-365.
2. Avorn, J., Dreyer, P., Connelly, K. and Soumerae, S. B. (1989). Use of psychoactive medication and the quality of care in rest homes: findings and policy implications of a statewide study. New England Journal of Medicine, 320, 227-232.
3. Bridges-Parlet, S., Knopman, D. and Steffes, S. (1997). Withdrawal of neuroleptic medications from institutionalized dementia patients: results of a double-blind, baseline-treatment-controlled pilot study. Journal of Geriatric Psychiatry and Neurology, 10, 119-126.
4. Buck, J. A. (1988). Psychotropic drug practice in nursing homes. Journal of the American Geriatrics Society, 36, 409-418.
5. Castle, N. G. (2001). Relocation of the elderly. Medical Care Research and Review. 58, 291-333.
6. Caligiuri, M. P., Rockwell, E. and Jeste, D. V. (1998). Extrapyramidal side-effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication. American Journal of Geriatric Psychiatry, 6, 75-82.
7. Conn, D. K., Ferguson, I., Mandelman, K. and Ward, C. (1999). Psychotropic drug utilization in long-term-care facilities for the elderly in Ontario, Canada. International Psychogeriatrics, 11, 223-233.
8. de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M., Datigues, J. F. and Baldereschi, M. (2000). Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 54, 11(Suppl 5) S21-23.
9. Dewa, C. S. and Goering, P. (2001). Lessons learned from trends in psychotropic drug expenditures in a Canadian province. Psychiatric Services, 52, 1245-1247.
10. Earthy, A., Collins, J., Wong, S. and Myckatyn, M. (2000). Ensuring the appropriate use of neuroleptics. Canadian Nursing Home, 11, 5-10.
11. Garrad, J., Makris, L., Dunham, T., Heston, L. L., Cooper, S. and Ratner, E. R. (1991). Evaluation of neuroleptic drug use by nursing home elderly under proposed medicare and Medicaid regulations. Journal of the American Medical Association, 265, 436-467.
12. Gurvich, T. and Cunningham, J. A. (2000). Appropriate use of psychotropic drugs in nursing homes. American Family Physician. 61, 1437-1446.
13. Hagen, B. and Armstrong-Esther, C. (1999). The question of neuroleptic use in LTC. Canadian Nursing Home, 10, 9-17.
14. Hughes, C., Lapane, K., Mor, V., Ikegami, N., Jonsson, P. V. and Ljunggren, G. (2000). The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. Journal of the American Geriatrics Society, 48, 931-937.
15. Jeste, D. V., Lacro, J. P., Palmer, B., Rockwell, E., Harris, M. J. and Caligiuri, M. P. (1999a). Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. American Journal of Psychiatry, 156, 309-311.
16. Jeste, D. V., Lacro, J. P., Bailey, A., Rockwell, E., Harris, M. J. and Caligiuri, M. P. (1999b). Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. Journal of the American Geriatrics Society, 47, 716-719.
17. Jeste, D. V., Rockwell, E., Harris, M. J., Lohr, L. B. and Lacro, J. (1999c). Conventional vs. newer antipsychotics in elderly patients. American Journal of Geriatric Psychiatry, 7, 70-76.
18. Johnson, R. A. and Hlava, C. (1994). Translocation of elders: maintaining the spirit. Geriatric Nursing, 15, 209-212.
19. Lantz, M. S., Giambanco, V. and Buchalter, E. N. (1996). A ten-year review of the effect of OBRA 87 on psychotropic prescribing practices in an academic nursing home. Psychiatric Services, 47, 951-955.
20. Lapane, K. L., Fernandez, H. H. and Friedman, J. H. (1999). Prevalence, clinical characteristics, and pharmacologic treatment of Parkinson's disease in residents in long-term care facilities. Pharmacotherapy, 19, 1321-1327.
21. Levenson, R. (1998). Drugs and Dementia: a Guide to Good Practice in the Use of Neuroleptic Drugs in Care Homes for Older People. London: Age Concern.
22. Llorente, M. D., Olsen, E. J., Leyva, O., Silverman, M. A., Lewis, J. E. and Rivero, J. (1998). Use of antipsychotic drugs in nursing homes: current compliance with OBRA regulations. Journal of the American Geriatrics Society, 46, 198-201.
23. McGrath, A. M. and Jackson, G. A. (1996). Survey of neuroleptic prescribing in residents of nursing homes in Glasgow. British Medical Journal, 312 (7031) 611-613.
24. Oborne, C. A., Hooper, R., Li, K. C., Swift, C. G. and Jackson, S. H. D. (2002). An indicator of appropriate neuroleptic prescribing in nursing homes. Age and Ageing, 31, 435-439.
25. Omnibus Budget Reconciliation Act of 1987. Subtitle C. Nursing Home Reform: PL100-203. Washington, D.C.: National Coalition for Nursing Home Reform.
26. Patterson, C. J. S., Gauthier, S., Bergman, H., Cohen, C. A., Feightner, J. and Feldman, H. W. (1999). The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Canadian Medical Association Journal, 160 (Suppl 12):S1-15.
27. Pett, M. A. (1997). Nonparametric Statistics for Health Care Research. Thousand Oaks: Sage.
28. Ray, W. A., Federspiel, C. F. and Schaffner, W. (1980). A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. American Journal of Public Health, 70, 485-91.
29. Rovner, B. W., Steele, C. D., Schmuely, Y. and Folstein, M. F. (1996). A randomized trial of dementia care in nursing homes. Journal of the American Geriatrics Society, 44, 7-13.
30. Ruth, S., Straand, J. and Nygaard, H. A. (2001). Psychotropic drug use in nursing homes-diagnostic indications and variations between institutions. European Journal of Clinical Pharmacology, 57, 523-528.
31. Semla, T. P., Palla, K., Poddig, B. and Brauner, D. J. (1994). Effect of the Omnibus Budget Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. Journal of the American Geriatrics Society, 42, 648-652.
32. Snowdon, J. and Vaughan, R. (1997). Changes in psychotropic medication use in nursing homes over a 9-month period. Journal of Quality in Clinical Practice, 17, 83-90.
33. Snowdon, J., Vaughan, R., Miller, R., Burgess, E. E. and Tremlett, P. (1995). Psychotropic drug use in Sydney nursing homes. Medical Journal of Australia, 163, 70-72.
34. Sorensen, L., Foldspang, A., Gulmann, N. C. and Munk-Jorgensen, P. (2001). Determinants for the use of psychotropics among nursing home residents. International Journal of Geriatric Psychiatry, 16, 147-154.
35. Thapa, P. B., Gideon, P., Fought, P. and Ray, W. A. (1995). Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents. American Journal of Epidemiology, 142, 202-211.
36. Thapa, P. B., Meador, K. G., Gideon, P., Fought, R. L. and Ray, W. A. (1994). Effects of antipsychotic withdrawal in elderly nursing home residents. Journal of the American Geriatrics Society, 42, 280-286.
37. Woerner, M. G., Alvir, J. M. J., Saltz, B. L., Liberman, J. A. and Kane, J. M. (1998). Prospective study of tardive dyskinesia in the elderly: rates and risk factors. American Journal of Psychiatry, 155, 1521-1529.